Articles related to BRAIN TUMORS

A national case-control study of 108,366 women found that prolonged use of injectable medroxyprogesterone acetate was associated with a 5.55-fold increased risk of intracranial meningioma requiring surgery (95% CI 2.27-13.56), while levonorgestrel IUDs showed no increased risk.

The newly developed Real-CSF test offers a significant leap in diagnosing brain tumors, accurately identifying cancerous lesions in 67% of cases by analyzing cerebrospinal fluid for abnormal genetic material.

A recent study on glioma brain tumors reveals the significant role of epigenetic changes in tumor formation. This discovery offers promising avenues for targeted therapies, potentially transforming the approach to treating this devastating disease.

Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.

Amar Gajjar, MD, who serves as the co-chair of the oncology department and chair of the pediatric medicine department at St. Jude Children’s Research Hospital in Memphis, Tennessee, answers questions from our friends at Cancer Therapy Advisor. Proton therapy, conventional chemotherapy, targeted therapies, and observed glioma progression are all topics covered by Dr. Gajjar when talking about treatment options for pediatric low-grade gliomas (pLGG) that have relapsed or progressed.